FORA Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

FORA Capital’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,504	Closed	-$741K	–	1036
2020 Q4	$741K	Buy	+13,504	New	+$492K	0.11%	202
2020 Q3	–	Sell	-3,022	Closed	-$63K	–	926
2020 Q2	$63K	Buy	+3,022	New	+$54.5K	0.02%	593

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

FORA Capital's RCKT Position: Q1 2021 in Review

FORA Capital sold out of Rocket Pharmaceuticals (RCKT) in Q1 2021, closing a stake of 13,504 shares — an estimated $741K sold.

FORA Capital first reported a position in RCKT in Q2 2020 and held it in 2 quarters. The position peaked at $741K in Q4 2020. 173 funds tracked by Wall St. Rank hold RCKT as of Q1 2021.

FORA Capital reported no remaining Rocket Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
FORA Capital sold 13,504 Rocket Pharmaceuticals shares in Q1 2021, an estimated $741K.
FORA Capital first reported a position in Rocket Pharmaceuticals in Q2 2020 and held it in 2 quarters.
FORA Capital's Rocket Pharmaceuticals position peaked at $741K in Q4 2020.
173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2021.

Based on FORA Capital's 13F filing for Q1 2021, filed 17 May 2021.